Scarica l'app Stockscreener
5.86
0.45%
-0.0264
Dopo l'orario di chiusura:
5.87
0.010
+0.17%
Precedente Chiudi:
$5.8864
Aprire:
$6
Volume 24 ore:
58,826
Relative Volume:
2.54
Capitalizzazione di mercato:
$24.32M
Reddito:
-
Utile/perdita netta:
$-14.56M
Rapporto P/E:
-0.3484
EPS:
-16.82
Flusso di cassa netto:
$-12.46M
1 W Prestazione:
-3.46%
1M Prestazione:
+1.65%
6M Prestazione:
-6.98%
1 anno Prestazione:
+68.88%
Intervallo 1D:
$5.601
$6.0535
Intervallo di 1 settimana:
$5.601
$6.3104
Portata 52W:
$2.77
$7.89
Tenax Therapeutics Inc Stock (TENX) Company Profile
Nome
Tenax Therapeutics Inc
Settore
Industria
Telefono
919-855-2100
Indirizzo
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Confronta TENX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
5.86 | 25.10M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 40.54M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ATHE
Alterity Therapeutics Ltd Adr
|
4.75 | 63.36M | 0 | 0 | 0 | 0.00 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
305.31 | 37.83B | 2.35B | -269.70M | -75.39M | -2.09 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-24 | Iniziato | Leerink Partners | Outperform |
| 2024-10-14 | Iniziato | Guggenheim | Buy |
| 2024-09-30 | Iniziato | William Blair | Outperform |
| 2017-05-18 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Iniziato | MLV & Co | Buy |
| 2014-11-18 | Iniziato | WallachBeth | Buy |
Mostra tutto
Tenax Therapeutics Inc Borsa (TENX) Ultime notizie
Where are the Opportunities in (TENX) - news.stocktradersdaily.com
Tectonic, Tenax, others aim for shift in heart failure - BioWorld MedTech
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments - TipRanks
William Blair Cuts Earnings Estimates for Tenax Therapeutics - Defense World
Leerink Partnrs Brokers Boost Earnings Estimates for TENX - Defense World
Roth Capital Issues Negative Forecast for TENX Earnings - Defense World
(TENX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
What is William Blair’s Estimate for TENX FY2028 Earnings? - Defense World
Roth Capital Has Bearish Forecast for TENX FY2028 Earnings - Defense World
Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com - Defense World
Tenax Therapeutics: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX S - GuruFocus
Analyst Adjusts Tenax Therapeutics (TENX) Price Target, Maintains Buy Rating | TENX Stock News - GuruFocus
Tenax Therapeutics (TENX) Advances Phase 3 Studies in 2025 | TEN - GuruFocus
Tenax Therapeutics Inc Reports Q1 2025 Net Loss of $10.4 Million Amid Rising R&D and Administrative Expenses - GuruFocus
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX Stock News - GuruFocus
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Tenax Advances Breakthrough PH-HFpEF Treatment: Phase 3 Trial Updates and $111M War Chest Revealed - Stock Titan
Tenax Therapeutics (TENX) Projected to Post Earnings on Tuesday - Defense World
(TENX) Technical Data - news.stocktradersdaily.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com - Defense World
Geode Capital Management LLC Boosts Stock Position in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com - Defense World
Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN
SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow
Form DEF 14A TENAX THERAPEUTICS, INC. For: Apr 24 - StreetInsider
Tenax Therapeutics Advances Cardiopulmonary Therapies - TipRanks
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - The Globe and Mail
Oxygen Biotherapeutics, Inc. : Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast - marketscreener.com
Teanx Therapeutics plans secondary offering - MSN
Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
Tenax Therapeutics (TENX) Files Prospectus for Stock Resale - GuruFocus
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Exclusive: Tenax Leadership Team to Unveil Latest Phase 3 Progress at Major Healthcare Conference - Stock Titan
What is Leerink Partnrs’ Forecast for TENX Q1 Earnings? - Defense World
Equities Analysts Offer Predictions for TENX Q1 Earnings - Defense World
Q1 Earnings Estimate for TENX Issued By William Blair - Defense World
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com - Defense World
Research Analysts Set Expectations for TENX Q1 Earnings - Defense World
When (TENX) Moves Investors should Listen - news.stocktradersdaily.com
Tenax Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tenax Therapeutics: Q4 Earnings Snapshot - CT Insider
Tenax Therapeutics Inc Azioni (TENX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.60%
3.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):